Sonio Secures $4 Million in Seed Funding to Revolutionize Women's Health Management Software

We are excited to announce that Sonio, the pioneering company committed to transforming women's healthcare through innovative technological solutions, has successfully raised $4 million in its latest funding round. This significant investment will be instrumental in further enhancing Sonio’s next-generation Women’s Health Practice Management and Reporting Software, which is designed to empower ultrasound practitioners, clinical executives, and IT teams. With the power of Artificial Intelligence, particularly through our FDA 510(k) cleared Sonio Detect product and MDR-CE marked Sonio Expert product, our platform ensures that every prenatal examination meets the highest quality standards. This funding will enable us to expand our product capabilities, enhance user experience, and drive extensive marketing efforts to reach more healthcare providers committed to excellence in prenatal care. As we continue to improve efficiency, quality assurance, and clinical outcomes throughout the patient's pregnancy journey, Sonio remains dedicated to supporting practitioners in delivering exceptional care. We thank our investors for their belief in our mission and look forward to the impactful advancements that will benefit healthcare providers and expectant families alike. Together, we will revolutionize women’s health and create a brighter, healthier future for mothers and their babies.